{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:00:42Z","timestamp":1790085642092,"version":"4.0.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M700629"],"award-info":[{"award-number":["2021M700629"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700046"],"award-info":[{"award-number":["81700046"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopha.2026.119896","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:09:08Z","timestamp":1788466148000},"page":"119896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Imeglimin improves mitochondrial quality and protects against lipopolysaccharide-induced acute lung injury by enhancing TXNIP promoter methylation"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3895-0112","authenticated-orcid":false,"given":"Dandan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Rong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9565-9654","authenticated-orcid":false,"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2026.119896_bib1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","volume":"315","author":"Bellani","year":"2016","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.biopha.2026.119896_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13054-017-1820-0","article-title":"Respiratory support in patients with acute respiratory distress syndrome: an expert opinion","volume":"21","author":"Chiumello","year":"2017","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.biopha.2026.119896_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/CCM.0000000000000715","article-title":"Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome","volume":"43","author":"Grissom","year":"2015","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119896_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00134-017-5035-2","article-title":"Prone position in ARDS: a simple maneuver still underused","volume":"44","author":"Chiumello","year":"2018","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119896_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"Pt 1","key":"10.1016\/j.biopha.2026.119896_bib6","article-title":"Endothelial septin 4 reduction contributes to lipopolysaccharide-induced acute lung injury by disrupting endothelial barrier integrity and promoting infiltration of ISG(+) cells","volume":"334","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119896_bib7","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00018-016-2449-x","article-title":"Actin dynamics in the regulation of endothelial barrier functions and neutrophil recruitment during endotoxemia and sepsis","volume":"74","author":"Schnoor","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119896_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2024.05.019","article-title":"Inflammatory lung injury is associated with endothelial cell mitochondrial fission and requires the nitration of RhoA and cytoskeletal remodeling","volume":"221","author":"Pokharel","year":"2024","journal-title":"Free. Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2026.119896_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101878","article-title":"The mitochondrial redistribution of eNOS is involved in lipopolysaccharide induced inflammasome activation during acute lung injury","volume":"41","author":"Wang","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2026.119896_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101936","article-title":"MitoQ protects against hyperpermeability of endothelium barrier in acute lung injury via a Nrf2-dependent mechanism","volume":"41","author":"Cen","year":"2021","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119896_bib11","first-page":"25","article-title":"PDCD4 knockdown ameliorates lipopolysaccharide-induced endothelial cell damage by improving mitochondrial dynamics","volume":"44","author":"Yu","year":"2024","journal-title":"Nan Fang. Yi Ke Da Xue Xue Bao"},{"issue":"8","key":"10.1016\/j.biopha.2026.119896_bib12","first-page":"1388","article-title":"Acetaldehyde dehydrogenase 2 ameliorates lung endothelial barrier and balances mitochondrial dynamics in mice with acute lung injury, Nan Fang Yi","volume":"43","author":"Wang","year":"2023","journal-title":"Ke Da Xue Xue Bao"},{"issue":"7-8","key":"10.1016\/j.biopha.2026.119896_bib13","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s10495-023-01847-z","article-title":"TFAM-Mediated mitochondrial transfer of MSCs improved the permeability barrier in sepsis-associated acute lung injury","volume":"28","author":"Zhang","year":"2023","journal-title":"Apoptosis"},{"issue":"2","key":"10.1016\/j.biopha.2026.119896_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40265-020-01434-5","article-title":"Imeglimin: current development and future potential in type 2 diabetes","volume":"81","author":"Konkwo","year":"2021","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.biopha.2026.119896_bib15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/dom.14277","article-title":"Mechanism of action of Imeglimin: a novel therapeutic agent for type 2 diabetes","volume":"23","author":"Hallakou-Bozec","year":"2021","journal-title":"Diabetes Obes. Metab."},{"issue":"6","key":"10.1016\/j.biopha.2026.119896_bib16","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.2337\/db14-1220","article-title":"Imeglimin normalizes glucose tolerance and insulin sensitivity and improves mitochondrial function in liver of a high-fat, high-sucrose diet mice model","volume":"64","author":"Vial","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2026.119896_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.70258","article-title":"Hepatoprotective effects of imeglimin are associated with preserved mitochondrial bioenergetics and reduced oxidative stress in a murine cholestasis model","author":"Goto","year":"2026","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.biopha.2026.119896_bib18","doi-asserted-by":"crossref","first-page":"15072","DOI":"10.1038\/cddiscovery.2015.72","article-title":"Imeglimin prevents human endothelial cell death by inhibiting mitochondrial permeability transition without inhibiting mitochondrial respiration","volume":"2","author":"Detaille","year":"2016","journal-title":"Cell. Death Discov."},{"issue":"9","key":"10.1016\/j.biopha.2026.119896_bib19","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/jdi.70092","article-title":"Imeglimin improves hyperglycemia and hypoglycemia-induced cell death and mitochondrial dysfunction in immortalized adult mouse Schwann IMS32 cells","volume":"16","author":"Kato","year":"2025","journal-title":"J. Diabetes Investig."},{"issue":"2","key":"10.1016\/j.biopha.2026.119896_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jphs.2024.03.004","article-title":"Imeglimin attenuates NLRP3 inflammasome activation by restoring mitochondrial functions in macrophages","volume":"155","author":"Lee","year":"2024","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2026.119896_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/s10787-026-02338-8","article-title":"Imeglimin confers protection against intestinal ischemia\/reperfusion injury in rats through AMPK-dependent inhibition of NF-\u03baB\/NLRP3 inflammasome signaling and mitigation of oxidative stress and apoptosis","author":"Abdelzaher","year":"2026","journal-title":"Inflammopharmacology"},{"issue":"2","key":"10.1016\/j.biopha.2026.119896_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1667\/RR15381.1","article-title":"K(ATP) channel blocker glibenclamide prevents radiation-induced lung injury and inhibits radiation-induced apoptosis of vascular endothelial cells by increased Ca(2+) influx and subsequent PKC activation","volume":"193","author":"Xia","year":"2020","journal-title":"Radiat. Res."},{"issue":"16","key":"10.1016\/j.biopha.2026.119896_bib23","first-page":"5355","article-title":"Metformin relieves acute respiratory distress syndrome by reducing miR-138 expression","volume":"22","author":"Yu","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119896_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00395-015-0465-x","article-title":"Gliptin and GLP-1 analog treatment improves survival and vascular inflammation\/dysfunction in animals with lipopolysaccharide-induced endotoxemia","volume":"110","author":"Steven","year":"2015","journal-title":"Basic. Res. Cardiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119896_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000168676","article-title":"Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis","volume":"77","author":"Aoki","year":"2009","journal-title":"Respiration"},{"key":"10.1016\/j.biopha.2026.119896_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1162159","article-title":"Insulin reverses impaired alveolar fluid clearance in ARDS by inhibiting LPS-induced autophagy and inflammatory","volume":"14","author":"Wen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119896_bib27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejphar.2016.10.016","article-title":"Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice","volume":"791","author":"Zhou","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119896_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112628","article-title":"The dynamic interplay between AMPK\/NF\u03baB signaling and NLRP3 is a new therapeutic target in inflammation: emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury","volume":"147","author":"Abd El-Fattah","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.biopha.2026.119896_bib29","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1165\/rcmb.2021-0531ST","article-title":"Update on the features and measurements of experimental acute lung injury in animals: an official American thoracic society workshop report","volume":"66","author":"Kulkarni","year":"2022","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"issue":"W1","key":"10.1016\/j.biopha.2026.119896_bib30","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: a web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy","volume":"45","author":"Yan","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"23","key":"10.1016\/j.biopha.2026.119896_bib31","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1128\/MCB.00227-07","article-title":"Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1","volume":"27","author":"Fujino","year":"2007","journal-title":"Mol. Cell. Biol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119896_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022806","article-title":"The role of the p38 MAPK signaling pathway in high glucose-induced epithelial-mesenchymal transition of cultured human renal tubular epithelial cells","volume":"6","author":"Lv","year":"2011","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.biopha.2026.119896_bib33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12035-025-05463-7","article-title":"Chronic oxaliplatin treatment induces CIPN in mice via activation of the TXNIP pathway","volume":"63","author":"Du","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119896_bib34","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1073\/pnas.89.10.4744","article-title":"Mechanism of human methyl-directed DNA methyltransferase and the fidelity of cytosine methylation","volume":"89","author":"Smith","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biopha.2026.119896_bib35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00018-002-8420-z","article-title":"DNA methylation and the regulation of gene transcription","volume":"59","author":"Attwood","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119896_bib36","first-page":"1135","article-title":"The potential roles of oral hypoglycemic agents to modulate mitochondrial function in type 1 diabetes mellitus: a scoping review","volume":"16","author":"Cheng","year":"2026","journal-title":"Life (Basel)"},{"key":"10.1016\/j.biopha.2026.119896_bib37","doi-asserted-by":"crossref","DOI":"10.1007\/s00592-026-02706-4","article-title":"Reversing diastolic dysfunction in diabetes: a mitochondrial quality control-centric pharmacological approach","author":"Fu","year":"2026","journal-title":"Acta Diabetol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119896_bib38","doi-asserted-by":"crossref","first-page":"E750","DOI":"10.1152\/ajpendo.00179.2019","article-title":"Mitochondrial dysfunction plays a key role in the development of neurodegenerative diseases in diabetes","volume":"318","author":"Cheng","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2026.119896_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.128","article-title":"Short-and long-term administration of imeglimin counters cardiorenal dysfunction in a rat model of metabolic syndrome","volume":"3","author":"Lachaux","year":"2020","journal-title":"Endocrinol. Diabetes Metab."},{"issue":"5","key":"10.1016\/j.biopha.2026.119896_bib40","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s12035-022-02765-y","article-title":"Imeglimin Is neuroprotective against ischemic brain injury in rats-a study evaluating neuroinflammation and mitochondrial functions","volume":"59","author":"Zemgulyte","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119896_bib41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jphs.2025.10.001","article-title":"Effects of imeglimin on mitochondrial functions and ischemic brain damage in young and aging rats","volume":"159","author":"Paskeviciene","year":"2025","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119896_bib42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.joca.2025.11.007","article-title":"Imeglimin, a novel antidiabetic agent related to metformin, attenuates knee osteoarthritis development and progression through AMPK activation and NF-\u03baB signaling inhibition","volume":"34","author":"Hyodo","year":"2026","journal-title":"Osteoarthr. Cartil."},{"issue":"23","key":"10.1016\/j.biopha.2026.119896_bib43","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1002\/1873-3468.70166","article-title":"Imeglimin attenuates liver fibrosis by inhibiting vesicular ATP release from hepatic stellate cells","volume":"599","author":"Nomura","year":"2025","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.biopha.2026.119896_bib44","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/dom.16157","article-title":"Efficacy of imeglimin in patients with type 2 diabetes mellitus complicated by metabolic dysfunction-associated steatotic liver disease: a multicentre study","volume":"27","author":"Fukunaga","year":"2025","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2026.119896_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12933-024-02189-z","article-title":"Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ","volume":"23","author":"Sanada","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119896_bib46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jphs.2023.07.002","article-title":"Imeglimin prevents visceral hypersensitivity and colonic hyperpermeability in irritable bowel syndrome rat model","volume":"153","author":"Nozu","year":"2023","journal-title":"J. Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2026.119896_bib47","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1463-1326.2012.01611.x","article-title":"Imeglimin, a novel glimin oral antidiabetic, exhibits a good efficacy and safety profile in type 2 diabetic patients","volume":"14","author":"Pirags","year":"2012","journal-title":"Diabetes Obes. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2026.119896_bib48","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2337\/dc12-0453","article-title":"The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy","volume":"36","author":"Fouqueray","year":"2013","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.biopha.2026.119896_bib49","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.2337\/dc13-2349","article-title":"The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with sitagliptin monotherapy","volume":"37","author":"Fouqueray","year":"2014","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.biopha.2026.119896_bib50","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/dom.12452","article-title":"Imeglimin increases glucose-dependent insulin secretion and improves \u03b2-cell function in patients with type 2 diabetes","volume":"17","author":"Pacini","year":"2015","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.biopha.2026.119896_bib51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/JIR.S84993","article-title":"Effects of exendin-4, a glucagon like peptide-1 receptor agonist, on neutrophil count and inflammatory cytokines in a rat model of endotoxemia","author":"Yanay","year":"2015","journal-title":"J. Inflamm. Res. 8"},{"issue":"3","key":"10.1016\/j.biopha.2026.119896_bib52","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/cells13030284","article-title":"Imeglimin exhibits novel anti-inflammatory effects on high-glucose-stimulated mouse microglia through ULK1-mediated suppression of the TXNIP-NLRP3 axis","volume":"13","author":"Kato","year":"2024","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.biopha.2026.119896_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/jor.70090","article-title":"Potential effect of imeglimin on mitochondrial function in subsynovial connective tissue of idiopathic carpal tunnel syndrome","volume":"44","author":"Ehara","year":"2026","journal-title":"J. Orthop. Res."},{"issue":"18","key":"10.1016\/j.biopha.2026.119896_bib54","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.3390\/ijms26188913","article-title":"Imeglimin alleviates high-glucose-induced bioenergetic and oxidative stress thereby enhancing intercellular adhesion in H9c2 cardiomyoblasts","volume":"26","author":"Ohguro","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2026.119896_bib55","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3390\/antiox13111415","article-title":"Imeglimin halts liver damage by improving mitochondrial dysfunction in a nondiabetic male mouse model of metabolic dysfunction-associated steatohepatitis","volume":"13","author":"Kaji","year":"2024","journal-title":"Antioxid. (Basel)"},{"issue":"9","key":"10.1016\/j.biopha.2026.119896_bib56","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2337\/db24-1090","article-title":"Adenylosuccinate mediates imeglimin-induced proliferative and antiapoptotic effects in \u03b2-cells","volume":"74","author":"Inoue","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2026.119896_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156458","article-title":"Imeglimin ameliorates MASLD by targeting PEN2 to activate AMPK pathway","volume":"175","author":"Li","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2026.119896_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122735","article-title":"Imeglimin modulates mitochondria biology and facilitates mitokine secretion in 3T3-L1 adipocytes","volume":"349","author":"Takahashi","year":"2024","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119896_bib59","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3390\/biomedicines10071757","article-title":"The thioredoxin system of mammalian cells and its modulators","volume":"10","author":"Hasan","year":"2022","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.biopha.2026.119896_bib60","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1089\/ars.2011.4322","article-title":"Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance","volume":"18","author":"Lee","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"9","key":"10.1016\/j.biopha.2026.119896_bib61","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3390\/antiox13091078","article-title":"Exploring the thioredoxin system as a therapeutic target in cancer: mechanisms and implications","volume":"13","author":"Seitz","year":"2024","journal-title":"Antioxid. (Basel)"},{"issue":"6","key":"10.1016\/j.biopha.2026.119896_bib62","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/FJC.0000000000001414","article-title":"Txnip gene knockout ameliorated high-fat diet-induced cardiomyopathy via regulating mitochondria dynamics and fatty acid oxidation","volume":"81","author":"Li","year":"2023","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"35","key":"10.1016\/j.biopha.2026.119896_bib63","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116505119","article-title":"Blocking CHOP-dependent TXNIP shuttling to mitochondria attenuates albuminuria and mitigates kidney injury in nephrotic syndrome","volume":"119","author":"Park","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119896_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117080","article-title":"Trifluoperazine exerts anti-osteosarcoma effect by inducing mitochondria-dependent apoptosis via AKT\/TXNIP signaling pathway","volume":"492","author":"Zeng","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119896_bib65","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41419-022-04758-0","article-title":"AGE-TXNIP axis drives inflammation in Alzheimer's by targeting A\u03b2 to mitochondria in microglia","volume":"13","author":"Sbai","year":"2022","journal-title":"Cell. Death Dis."},{"issue":"2","key":"10.1016\/j.biopha.2026.119896_bib66","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2337\/db09-0949","article-title":"Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated beta-cell death","volume":"59","author":"Chen","year":"2010","journal-title":"Diabetes"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:10:04Z","timestamp":1790082604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226009327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":66,"alternative-id":["S0753332226009327"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119896","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imeglimin improves mitochondrial quality and protects against lipopolysaccharide-induced acute lung injury by enhancing TXNIP promoter methylation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119896"}}